CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance
- PMID: 20802159
- PMCID: PMC2952571
- DOI: 10.1194/jlr.M010256
CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance
Abstract
Mutations of Comparative Gene Identification-58 (CGI-58) in humans cause triglyceride (TG) accumulation in multiple tissues. Mice genetically lacking CGI-58 die shortly after birth due to a skin barrier defect. To study the role of CGI-58 in integrated lipid and energy metabolism, we utilized antisense oligonucleotides (ASOs) to inhibit CGI-58 expression in adult mice. Treatment with two distinct CGI-58-targeting ASOs resulted in ∼80-95% knockdown of CGI-58 protein expression in both liver and white adipose tissue. In chow-fed mice, ASO-mediated depletion of CGI-58 did not alter weight gain, plasma TG, or plasma glucose, yet raised hepatic TG levels ∼4-fold. When challenged with a high-fat diet (HFD), CGI-58 ASO-treated mice were protected against diet-induced obesity, but their hepatic contents of TG, diacylglycerols, and ceramides were all elevated, and intriguingly, their hepatic phosphatidylglycerol content was increased by 10-fold. These hepatic lipid alterations were associated with significant decreases in hepatic TG hydrolase activity, hepatic lipoprotein-TG secretion, and plasma concentrations of ketones, nonesterified fatty acids, and insulin. Additionally, HFD-fed CGI-58 ASO-treated mice were more glucose tolerant and insulin sensitive. Collectively, this work demonstrates that CGI-58 plays a critical role in limiting hepatic steatosis and maintaining hepatic glycerophospholipid homeostasis and has unmasked an unexpected role for CGI-58 in promoting HFD-induced obesity and insulin resistance.
Figures
![Fig. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2952571/bin/3306fig1.gif)
![Fig. 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2952571/bin/3306fig2.gif)
![Fig. 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2952571/bin/3306fig3.gif)
![Fig. 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2952571/bin/3306fig4.gif)
![Fig. 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2952571/bin/3306fig5.gif)
Similar articles
-
CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance.Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):1869-74. doi: 10.1073/pnas.1219456110. Epub 2013 Jan 9. Proc Natl Acad Sci U S A. 2013. PMID: 23302688 Free PMC article.
-
Growth retardation, impaired triacylglycerol catabolism, hepatic steatosis, and lethal skin barrier defect in mice lacking comparative gene identification-58 (CGI-58).J Biol Chem. 2010 Mar 5;285(10):7300-11. doi: 10.1074/jbc.M109.081877. Epub 2009 Dec 18. J Biol Chem. 2010. PMID: 20023287 Free PMC article.
-
Multiple antisense oligonucleotides targeted against monoacylglycerol acyltransferase 1 (Mogat1) improve glucose metabolism independently of Mogat1.Mol Metab. 2021 Jul;49:101204. doi: 10.1016/j.molmet.2021.101204. Epub 2021 Mar 3. Mol Metab. 2021. PMID: 33676028 Free PMC article.
-
Recent insights into the structure and function of comparative gene identification-58.Curr Opin Lipidol. 2011 Jun;22(3):149-58. doi: 10.1097/MOL.0b013e328346230e. Curr Opin Lipidol. 2011. PMID: 21494142 Free PMC article. Review.
-
Antisense Oligonucleotide Technologies to Combat Obesity and Fatty Liver Disease.Front Physiol. 2022 Jan 28;13:839471. doi: 10.3389/fphys.2022.839471. eCollection 2022. Front Physiol. 2022. PMID: 35295579 Free PMC article. Review.
Cited by
-
Membrane-bound O-acyltransferase 7 (MBOAT7) shapes lysosomal lipid homeostasis and function to control alcohol-associated liver injury.Elife. 2024 Apr 22;12:RP92243. doi: 10.7554/eLife.92243. Elife. 2024. PMID: 38648183 Free PMC article.
-
Elevated Kallistatin promotes the occurrence and progression of non-alcoholic fatty liver disease.Signal Transduct Target Ther. 2024 Mar 12;9(1):66. doi: 10.1038/s41392-024-01781-9. Signal Transduct Target Ther. 2024. PMID: 38472195 Free PMC article.
-
ABHD5-A Regulator of Lipid Metabolism Essential for Diverse Cellular Functions.Metabolites. 2022 Oct 24;12(11):1015. doi: 10.3390/metabo12111015. Metabolites. 2022. PMID: 36355098 Free PMC article. Review.
-
Knockdown of hepatocyte Perilipin-3 mitigates hepatic steatosis and steatohepatitis caused by hepatocyte CGI-58 deletion in mice.J Mol Cell Biol. 2022 Dec 26;14(8):mjac055. doi: 10.1093/jmcb/mjac055. J Mol Cell Biol. 2022. PMID: 36107452 Free PMC article.
-
Protective Effects of Tiaoganquzhi Decoction in Treating inflammatory Injury of Nonalcoholic Fatty liver Disease by Promoting CGI-58 and Inhibiting Expression of NLRP3 Inflammasome.Front Pharmacol. 2022 May 2;13:851267. doi: 10.3389/fphar.2022.851267. eCollection 2022. Front Pharmacol. 2022. PMID: 35586044 Free PMC article.
References
-
- Igal R. A., Rhoads J. M., Coleman R. A. 1997. Neutral lipid storage disease with fatty liver and cholestasis. J. Pediatr. Gastroenterol. Nutr. 25: 541–547. - PubMed
-
- Dorfman M. L., Hershko C., Eisenberg S., Sagher F. 1974. Ichthyosiform dermatosis with systemic lipidosis. Arch. Dermatol. 110: 261–266. - PubMed
-
- Lefevre C., Jobard F., Caux F., Bouadjar B., Karaduman A., Heilig R., Lakhdar H., Wollenberg A., Verret J. L., Weissenbach J., et al. 2001. Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome. Am. J. Hum. Genet. 69: 1002–1012. - PMC - PubMed
-
- Hilaire N., Negre-Salvayre A., Salvayre R. 1993. Cytoplasmic triacylglycerols and cholesteryl esters are degraded in two separate catabolic pools in cultured human fibroblasts. FEBS Lett. 328: 230–234. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 1K99-HL096166-01/HL/NHLBI NIH HHS/United States
- 5P01HL057278-09/HL/NHLBI NIH HHS/United States
- 5P01HL049373-17/HL/NHLBI NIH HHS/United States
- P01 HL049373/HL/NHLBI NIH HHS/United States
- P01 HL057278/HL/NHLBI NIH HHS/United States
- R00 HL096166/HL/NHLBI NIH HHS/United States
- F32 DK084582/DK/NIDDK NIH HHS/United States
- K99 HL096166/HL/NHLBI NIH HHS/United States
- U24 DK059635/DK/NIDDK NIH HHS/United States
- 1F32DK084582-01/DK/NIDDK NIH HHS/United States
- R01 DK040936/DK/NIDDK NIH HHS/United States
- R01 DK085176/DK/NIDDK NIH HHS/United States
- T32 HL091797/HL/NHLBI NIH HHS/United States
- R01DK085176/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous